Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 237

The DOI matches its Crossref record.

Safety Study of Nonoxynol-9 as a Vaginal Microbicide: Evidence of Adverse Effects

Stafford, Michael K., Ward, Helen, Flanagan, Adrienne, Rosenstein, Isobel J., Taylor-Robinson, David, Smith, J. Richard, Weber, Jonathan, Kitchen, Valerie S.·1998·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Abstract

Nonoxynol-9 (N-9) is virucidal in vitro, and is therefore a candidate microbicide for preventing sexual transmission of HIV. However, the activity of N-9 is nonspecific, suggesting that virucidal levels may produce adverse effects including epithelial disruption, inflammation of the genital mucosa, or both. A randomized placebo controlled trial of daily use of 100 mg of N-9 took place for 1 week in 40 female volunteers. Outcome measures included symptoms, colposcopic and histologic changes in the genital tract, and impact on vaginal flora. Genital irritation was reported by 10 of the N-9 and 5 of the placebo group. Colposcopy showed erythema in 9 of the N-9 group and 2 of the placebo group. Histologic inflammation was found in 7 of the N-9 group and 2 of the placebo group. Inflammatory changes were characterized by patchy infiltration of the lamina propria predominantly with CD8+ lymphocytes and macrophages, in the absence of epithelial disruption. A transient reduction in numbers of lactobacilli was observed in 9 of the 15 women using N-9, and 6 of 18 women using placebo. N-9 used for 7 days in a standard spermicidal dose was associated with increased irritation, colposcopic and histologic evidence of inflammation and was more frequently associated with reduction in numbers of lactobacilli during gel use. The clinical significance of the recruitment of cells susceptible to HIV infection to the genital mucosa is unknown but raises concerns about the suitability of N-9 as a microbicide when given in this dose.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/00042560-199804010-00006

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 237

Metadata

Authors
Stafford, M. K., Ward, H., Flanagan, A., Rosenstein, I. J., Taylor-Robinson, D., Smith, J. R., Weber, J., & Kitchen, V. S.
Venue
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology
Published
1998-04
Volume
17
Issue
4
Pages
327-331
ISSN
1077-9450 (ISSN-L)
OpenAlex
W2090864305
Cited by
237
References
0
FWCI
13.76
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Safety Study of Nonoxynol-9 as a Vaginal Microbicide: Evidence of Adverse Effects. https://app.cochat.ai/papers/10.1097/00042560-199804010-00006
The paper
Stafford, M. K., Ward, H., Flanagan, A., Rosenstein, I. J., Taylor-Robinson, D., Smith, J. R., Weber, J., & Kitchen, V. S. (1998). Safety Study of Nonoxynol-9 as a Vaginal Microbicide: Evidence of Adverse Effects. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. https://doi.org/10.1097/00042560-199804010-00006

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.